about
Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohortAssociation of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis.Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis.Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies.Is there a role of synovial biopsy in drug development?MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritisThe role of resistin in inflammatory myopathies.An update on biomarkers in axial spondyloarthritis.Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts.7th meeting of the Global Arthritis Research Network.Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis.Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early diseasePro-inflammatory effects of interleukin-35 in rheumatoid arthritisAdiponectin relation to skin changes and dyslipidemia in systemic sclerosisAdipokine profile is modulated in subcutaneous adipose tissue by TNF inhibitors in patients with rheumatoid arthritisModulation of subcutaneous adipose tissue adipokines by TNF- blockade therapy in patients with inflammatory arthritidesThe level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapyVaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritisCitrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblastsSerum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritisSerum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study
P50
Q30839061-3B0C171C-F8DD-4E94-B824-6AF555DC524CQ34237586-4AFD550C-6D43-42E6-BD64-1A6E7D4CF635Q35882730-296118EA-4657-4300-9F08-7928F191CB1EQ35906327-8676099F-4888-4052-96BD-D4B2B8026957Q35994130-C1CB434F-A19A-4E92-B7CC-BF987DADE2D3Q36960767-397A4B47-81BB-40E0-961E-EFD2CF0F038FQ38099557-A356323C-32DF-4618-8968-072359F3762FQ38724854-4CDD0803-0BD6-4958-A592-5E0020D2599CQ42479250-0F7E88B5-FF59-4C05-9819-449B93F44C27Q43013694-1F50F57A-25E6-4ADD-B2DC-A94B266DD7AFQ51663216-5ACF8337-46B3-49AC-852D-47D6BC5D9E5FQ57752293-5748AF51-078C-4C30-93B8-B2F51ECA67CFQ57752308-8C08E08E-D677-447B-964A-1C8BA72068E8Q57752460-26F8C320-C925-4F11-87DF-32328133C8B6Q57752526-5E8D3F4B-531B-4D09-A4C3-17D8123F5E5EQ57752546-C654F946-FB90-45B2-AE32-2D6866E56FA7Q57752573-96B72A53-04DE-44D7-98AE-3E9041F9BA6BQ57752623-AE045C2A-D73B-48E9-8453-B8A2E6DE4D6AQ61253317-AE06E640-75E2-4FC0-BFD9-A53046B3058AQ61787539-70426258-B9E2-474B-834F-4C55E838F8B1Q91532373-38945CE1-357B-4ACD-B45E-9E9986730806
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Filkova
@ast
Maria Filkova
@en
Maria Filkova
@es
Maria Filkova
@nl
Maria Filkova
@sl
type
label
Maria Filkova
@ast
Maria Filkova
@en
Maria Filkova
@es
Maria Filkova
@nl
Maria Filkova
@sl
prefLabel
Maria Filkova
@ast
Maria Filkova
@en
Maria Filkova
@es
Maria Filkova
@nl
Maria Filkova
@sl
P1053
M-9307-2017
P106
P21
P31
P3829
P496
0000-0002-8488-9227